Vinita Kailasanath</a>, a partner in the Silicon Valley office of <a href=https://medcitynews.com/author/vkailasanathspark/"https://www.freshfields.us/">Freshfields, has extensive experience in strategic intellectual property and data-driven transactions in life sciences and technology, and particularly at their intersection. She represents life sciences companies, technology companies, healthcare companies and providers, private equity firms and other investors in connection with the execution of their cutting-edge MedTech and digital health strategies in addition to their other complex licenses and collaborations, strategic investments, and R&D and supply agreements. Ms. Kailasanath has advised clients on transactions involving medical devices (including SaMD), wearables, mobile apps, telemedicine, artificial intelligence/machine learning, software, hardware, pharmaceutical products and biologics. Vinita also routinely advises on the intellectual property aspects of mergers, acquisitions and joint ventures. Vinita avidly tracks trends in MedTech and the associated legal considerations and publishes a quarterly <a href=https://medcitynews.com/author/vkailasanathspark/"https://www.freshfields.com/en-gb/our-thinking/campaigns/technology-quotient/medtech/medtech-trends-update/">MedTech Update</a>. <a href=https://medcitynews.com/author/vkailasanathspark/"https://www.linkedin.com/in/sora-park-380a3652/">Sora Park</a> is an Associate at <a href=https://medcitynews.com/author/vkailasanathspark/"https://www.freshfields.us/">Freshfields and focuses her practice on a variety of life sciences and technology transactions. Her experience includes assisting clients in drafting and negotiating agreements involving the research, development and commercialization of new technologies and products, software licensing, and manufacturing and supply relationships. Sora also provides support on the intellectual property aspects of mergers and acquisitions." /> Vinita Kailasanath and Sora Park, Author at MedCity News

Vinita Kailasanath and Sora Park

Vinita Kailasanath, a partner in the Silicon Valley office of Freshfields, has extensive experience in strategic intellectual property and data-driven transactions in life sciences and technology, and particularly at their intersection. She represents life sciences companies, technology companies, healthcare companies and providers, private equity firms and other investors in connection with the execution of their cutting-edge MedTech and digital health strategies in addition to their other complex licenses and collaborations, strategic investments, and R&D and supply agreements. Ms. Kailasanath has advised clients on transactions involving medical devices (including SaMD), wearables, mobile apps, telemedicine, artificial intelligence/machine learning, software, hardware, pharmaceutical products and biologics. Vinita also routinely advises on the intellectual property aspects of mergers, acquisitions and joint ventures. Vinita avidly tracks trends in MedTech and the associated legal considerations and publishes a quarterly MedTech Update.

Sora Park is an Associate at Freshfields and focuses her practice on a variety of life sciences and technology transactions. Her experience includes assisting clients in drafting and negotiating agreements involving the research, development and commercialization of new technologies and products, software licensing, and manufacturing and supply relationships. Sora also provides support on the intellectual property aspects of mergers and acquisitions.

Posts by Vinita Kailasanath and Sora Park